期刊
ANNALS OF HEPATOLOGY
卷 19, 期 4, 页码 353-358出版社
ELSEVIER ESPANA
DOI: 10.1016/j.aohep.2020.05.001
关键词
SARS-CoV-2; Coronavirus; Liver disease; Transplantation; Cirrhosis
资金
- CONICYT (Comite Nacional de Ciencia y Tecnologia) [FONDECYT N 1191389]
The ongoing pandemic of coronavirus disease 2019 (COVID-19) pandemic poses a serious threat to healthcare systems globally. Information regarding how the infection affects the liver and relevance of pre-existing liver disease as a risk factor for acquiring the infection or having a severe disease are still scarce. Also, considerations in liver transplant patients, those having hepatocellular carcinoma or under immunosuppressive therapy are being matter of analysis as information is being generated. Different treatments for COVID-19 are currently under study, some of which may be associated to hepatotoxicity. In the present review we discuss current data on the COVID-19 and liver, aiming to provide hepatologists with updated information to face this pandemic. (C) 2020 Fundacion Clinica Medica Sur, A.C. Published by Elsevier Espana, S.L.U.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据